1.In vitro anti-viral activity of hexetidine (Bactidol®) oral mouthwash against human coronavirus OC43 and influenza A (H1N1) virus
Marohren C. Tobias-Altura ; Corazon A. Ngelangel
Philippine Journal of Health Research and Development 2022;26(College of Public Health Issue):1-6
Background:
Mouthwashes are used to decrease oral cavity microbial load due to their antiseptic properties. Hexetidine is a broad-spectrum antiseptic used for minor infections of mucous membranes, and, as a 0.1% mouthwash for local infections and oral hygiene.
Objectives:
This study determined the anti-viral activity of the mouthwash hexetidine (Bactidol®), specifically in reducing viral concentration of Human Coronavirus OC43 (HCoV- OC43; ATCC®VR-1558™) and Influenza A virus (IAV H1N1; clinical strain) cultured in cell lines.
Methodology:
In-vitro suspension assay (ASTM E-1052-11) was used to evaluate the virucidal property of
hexetidine. Tissue Culture Infective Dose or TCID50/ml in 25%, 50%, and 100% hexetidine concentration at
15- and 30-seconds were determined. Vero E6 and MDCK cell lines were utilized for HCoV OC43 and IAV H1N1, respectively.
Results:
Hexetidine-treated cell lines achieved >80% survival rate for MDCK and Vero E6. Hexetidine reduced the infectivity of HCoV-OC43 and IAV H1N1 at 25%, 50%, and 100% concentrations by more than 80% at 15- and 30-seconds exposure times.
Conclusion and Recommendation
This in vitro study showed that hexetidine, even at diluted concentrations, reduced the infectivity of HCoV-OC43 and Influenza A virus H1N1 when used for 15 and 30 seconds. The antiviral activity of hexetidine mouthwash against the other virulent members of the Coronavirus Family, SARSCoV- 2 can be explored using the methods used in this in vitro study.
Hexetidine
;
Influenza A virus
2.In Vitro Antibacterial and Antibiofilm activities of Piper betle L. Ethanolic Leaf Extract on Staphylococcus aureus ATCC 29213
Ryan Christopher C. Lao ; Ailyn M. Yabes ; Marohren Tobias-Altura ; Lynn Crisanta R. Panganiban ; Irma R. Makalinao
Acta Medica Philippina 2020;54(Online):1-8
Background and Objective:
Staphylococcus aureus is the leading cause of skin and soft tissue infections such as abscesses, furuncles, and cellulitis. Biofilm forming strains of S. aureus have higher incidence of antimicrobial resistance to at least three or more antibiotics and are considered as multidrug resistant. Since S. aureus biofilm-producing strains have higher rates of multidrug and methicillin resistance compared to non-biofilm-producing strains, the need for alternative therapeutic option is important. Furthermore, rates of methicillin-resistant Staphylococcus aureus (MRSA) in Asia remain high. Results of the study may provide support for the clinical uses of P. betle as a topical antibacterial and antiseptic in the treatment and prevention of infections involving the skin, mouth, throat, and indwelling medical devices. Thus, this study aimed to evaluate the in vitro antibacterial and antibiofilm activities of Piper betle L. ethanolic leaf extract (PBE) against a biofilm-forming methicillin-sensitive Staphylococcus aureus ATCC 29213 (MSSA).
Methods:
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of PBE against MSSA were determined using the agar dilution assay. The biofilm inhibition and eradication assays using crystal violet were done to quantify the antibiofilm activities of PBE on MSSA biofilm.
Results:
PBE showed activity against MSSA in agar dilution assay with MIC and MBC values of 2500 μg/mL and
5000 μg/mL, respectively. At subinhibitory concentrations, PBE showed biofilm inhibition activity at 1250 μg/mL but a lower percent eradication of biofilms as compared to oxacillin was noted.
Conclusion
PBE showed antibacterial activities including biofilm inhibition against methicillin-sensitive Staphylococcus aureus ATCC 29213 (MSSA).
Piper betle
;
Staphylococcus aureus
;
Anti-Bacterial Agents
;
Biofilms
3.In vitro antibacterial and antibiofilm activities of Piper betle L. ethanolic leaf extract on staphylococcus aureus ATCC 29213
Ryan Christopher C. Lao ; Ailyn M. Yabes ; Marohren Tobias-Altura ; Lynn Crisanta R. Panganiban ; Irma R. Makalinao
Acta Medica Philippina 2023;57(12):53-60
Background and Objective:
Staphylococcus aureus is the leading cause of skin and soft tissue infections such as abscesses, furuncles, and cellulitis. Biofilm forming strains of S. aureus have higher incidence of antimicrobial resistance to at least three or more antibiotics and are considered as multidrug resistant. Since S. aureus biofilm-producing strains have higher rates of multidrug and methicillin resistance compared to non-biofilm-producing strains, the need for alternative therapeutic option is important. Furthermore, rates of methicillin-resistant Staphylococcus aureus (MRSA) in Asia remain high. Results of the study may provide support for the clinical uses of P. betle as a topical antibacterial and antiseptic in the treatment and prevention of infections involving the skin, mouth, throat, and indwelling medical devices. Thus, this study aimed to evaluate the in vitro antibacterial and antibiofilm activities of Piper betle L. ethanolic leaf extract (PBE) against a biofilm-forming methicillin-sensitive Staphylococcus aureus ATCC 29213 (MSSA).
Methods:
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of PBE against MSSA were determined using the agar dilution assay. The biofilm inhibition and eradication assays using crystal violet were done to quantify the antibiofilm activities of PBE on MSSA biofilm.
Results:
PBE showed activity against MSSA in agar dilution assay with MIC and MBC values of 2500 μg/mL and
5000 μg/mL, respectively. At subinhibitory concentrations, PBE showed biofilm inhibition activity at 1250 μg/mL but a lower percent eradication of biofilms as compared to oxacillin was noted.
Conclusion
PBE showed antibacterial activities including biofilm inhibition against methicillin-sensitive Staphylococcus aureus ATCC 29213 (MSSA).
Piper betle
;
Staphylococcus aureus
;
Anti-Bacterial Agents
;
Biofilms
4.Identification of nontuberculous mycobacteria in patients with multidrug-resistant tuberculosis in Quezon City, Philippines, using multiplex PCR.
Michelle M. CABANATAN ; Alice Alma C. BUNGAY ; Sharon Yvette Angelina M. VILLANUEVA ; Marohren C. TOBIAS-ALTURA ; Dario D. DEFENSOR ; Maria Margarita M. LOTA
Acta Medica Philippina 2025;59(4):103-112
BACKGROUND AND OBJECTIVE
Nontuberculous mycobacteria (NTM) lung disease appears like tuberculosis infection but is resistant to primary anti-tuberculosis drugs. Hence, patients whose sputum sample tests positive for acid-fast bacilli (AFB) and bacterial culture for several times should be assessed for colonization or infection with NTM in a damaged lung secondary to TB. In such cases, though drug-resistant TB may be adequately treated, treatment may need to be directed towards the NTM as well. In NTM therapy, the duration and choice of treatment agent is based upon the specific organism and disease extent. This study used one-step multiplex PCR (mPCR) assay for rapid differentiation of solid cultures in Ogawa medium as Mycobacterium tuberculosis (MTB) and/or NTM.
METHODSA total of 80 stocked isolates obtained from the Lung Center of the Philippines from January to December 2018 were screened for NTM in terms of growth in Ogawa medium, acid fastness, and MPT64 TB antigen test result. These were from sputum specimens of multidrug-resistant tuberculosis (MDR-TB) patients. DNA was extracted from cultures (n=55) grown in Ogawa medium and one-step mPCR was performed to identify NTM to the species level.
RESULTSOut of 80 samples screened, a total of 55 isolates were identified as NTM. One-step mPCR identified 12.73% (7/55) as M. abscessus, 34.55% (19/55) as M. massiliense, 1.82% (1/55) as M. kansasii, and 50.91% (28/55) were identified only up to genus Mycobacteria spp. Neither M. avium complex nor M. intracellulare was identified among the samples tested.
CONCLUSIONOne-step mPCR was able to identify isolates as MTB or NTM coinciding with the initial screening using MPT64 TB antigen test. Multiplex PCR has given a more specific identificati on to the species level. The use of mPCR in identifying MTB and clinically significant NTM’s is suitable for the adequate treatment of mycobacterial infection.
Human ; Bacteria ; Multiplex Pcr ; Multiplex Polymerase Chain Reaction ; Mycobacteria ; Mycobacterium ; Tuberculosis, Multidrug-resistant